Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Antengene Corporation

Clinical trials sponsored by Antengene Corporation, explained in plain language.

Now part of Antengene Corporation Limited 6996 HKEX

A biopharmaceutical company developing oncology drugs.

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Completed 1 Terminated 1

Lymphoma drug combo trial halted early

Disease control Terminated

This study tested a drug called selinexor combined with chemotherapy or another drug (tislelizumab) in people with relapsed or hard-to-treat T and NK cell lymphoma. The goal was to see if the combination was safe and could shrink tumors. The trial was stopped early, so results ar…

Phase: PHASE1, PHASE2 • Sponsor: Antengene Corporation • Aim: Disease control

Last updated Jun 27, 2026 08:08 UTC